PT  - JOURNAL ARTICLE
AU  - Caroline Prouillac
AU  - Sylvaine Lecoeur
TI  - The Role of the Placenta in Fetal Exposure to Xenobiotics: Importance of Membrane Transporters and Human Models for Transfer Studies
AID  - 10.1124/dmd.110.033571
DP  - 2010 Oct 01
TA  - Drug Metabolism and Disposition
PG  - 1623--1635
VI  - 38
IP  - 10
4099  - http://dmd.aspetjournals.org/content/38/10/1623.short
4100  - http://dmd.aspetjournals.org/content/38/10/1623.full
SO  - Drug Metab Dispos2010 Oct 01; 38
AB  - The placenta is a key organ in fetal growth and development because it controls maternal-to-fetal exchanges of nutrients and hormones. It also interferes with drug delivery to the fetus by expressing active membrane transporters and xenobiotic metabolism enzymes. Developing strategies to understand the role of the placenta in drug delivery is a challenge in toxicology. Despite common physiological functions, the placentas of different species are heterogeneous in their morphology and in their expression of membrane transporters and metabolizing proteins. These characteristics raise the difficulty of obtaining a good representative model of human placental transfer. To date, different in vitro, in vivo, and ex vivo tools have been used to elucidate transport and metabolism processes in the human placenta. This study recapitulates the typical features of human placenta and then presents the placental enzymes of xenobiotic metabolism, ATP-binding cassette transporters, solute carrier transporters, and their role in fetal exposure to xenobiotics. The study also compares the characteristics of different models of human placenta, in terms of membrane localization of transporters, and the expression of xenobiotic metabolism enzymes. The use of these models for toxicological studies, in particular xenobiotic transfer, is described, and the advantages and limits of each model are summarized.